Ya-Bin Gong
Overview
Explore the profile of Ya-Bin Gong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Induction of Senescence in Lung Cancer Cells by Qidongning Formula via the Transcription Factor EGR1
Zhou D, Yang W, Wang C, Qian C, Xu L, Dong C, et al.
Integr Cancer Ther
. 2025 Mar;
24:15347354241307007.
PMID: 40029995
The purpose of this study was to investigate the role of the early growth response gene 1 (EGR1) in inducing senescence in lung cancer cells by Qidongning Formula (QDF). Cell-Counting-Kit-8...
2.
Zhang Y, Jiao L, Gong Y, Xu J, Ni J, Shen X, et al.
Chin J Integr Med
. 2024 Sep;
30(11):963-973.
PMID: 39266862
Objective: To investigate whether the combination of chemotherapy with staged Chinese herbal medicine (CHM) therapy could enhance health-related quality of life (QoL) in non-small-cell lung cancer (NSCLC) patients and prolong...
3.
Zeng L, Cui J, Jiang T, Tu L, Liu H, Gong Y, et al.
Technol Health Care
. 2023 Dec;
32(3):1403-1420.
PMID: 38043028
Background: Tongue diagnosis is a crucial traditional Chinese medicine (TCM) inspection method for TCM syndrome differentiation and treatment. Objective: The primary research focus was on tongue image characteristic parameters of...
4.
Li Q, Yang W, Yao L, Chen H, Li Z, Gong Y, et al.
Pain Ther
. 2023 Aug;
12(6):1355-1374.
PMID: 37578681
Introduction: This study aims to investigate the regularity of related parameters in the treatment of cancer pain using transcutaneous electrical nerve stimulation (TENS). Methods: A comprehensive literature search was conducted...
5.
Li Q, Yang W, Liu H, Jiao L, Gong Y, Shi J
Integr Cancer Ther
. 2023 Aug;
22:15347354231192017.
PMID: 37551854
Background: Cancer pain, a common complication of this disease, has been widely treated by electroacupuncture in recent years. However, there are numerous treatment parameters that are not conducive to clinical...
6.
Yao J, Yang W, Wang Y, Jiao L, Shi J, Gong Y
Zhongguo Zhen Jiu
. 2023 May;
42(10):1125-8.
PMID: 37199203
Objective: To observe the clinical efficacy of blade acupuncture combined with functional exercise for chronic pain after non-small cell lung cancer surgery. Methods: A total of 62 patients with chronic...
7.
Gong Y, Yang Z, Liu Y, Zhang Y, Jiang K, Shi X, et al.
World J Acupunct Moxibustion
. 2020 Aug;
30(3):171-174.
PMID: 32837108
The paper reports the experiences in treatment of two cases of corona virus disease 2019 (COVID-19) with the combination of acupuncture and medication in bedridden patients confirmed in C7 Inpatient...
8.
Cao F, Gong Y, Kang X, Lu Z, Wang Y, Zhao K, et al.
Toxicol Appl Pharmacol
. 2019 Jul;
379:114662.
PMID: 31301315
Although osimertinib, an EGFR tyrosine kinase inhibitor, has become the standard therapy for treating non-small cell lung cancer (NSCLC) patients with EGFR-activating mutation, upregulation of MCL-1 induces acquired resistance to...
9.
Kang X, Gong Y, Wang L, Wang Z, Deng H, Zhao X, et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi
. 2013 Dec;
33(8):1081-5.
PMID: 24325059
Objective: To observe the effect of bufalin combined Gefitinib on lung cancer H1975 cells, and to explore its potential mechanisms for anti-tumor. Methods: The cytostatic effects of bufalin (1 -100...
10.
Kang X, Xu Z, Gong Y, Wang L, Wang Z, Xu L, et al.
Evid Based Complement Alternat Med
. 2013 Mar;
2013:243859.
PMID: 23533466
The epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, have shown promising therapeutic efficacy in nonsmall cell lung cancer (NSCLC) patients harboring epidermal growth factor...